跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
高 偉棠
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0001-8888-8769
電子郵件
12319
s.tmu.edu
tw
h-index
40
引文
4
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2023
每年研究成果
概覽
指紋
網路
研究成果
(15)
類似的個人檔案
(8)
指紋
查看啟用 Wei-Tang Kao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Ureter
100%
Demography
88%
Overall Survival
88%
Observational Study
83%
Influenza Vaccination
83%
Transitional Cell Carcinoma
83%
Clear Cell Renal Cell Carcinoma
83%
Injury
83%
End Stage Renal Disease
83%
Apoptosis Inhibitor
83%
Prostate Specific Antigen
83%
Upper Urinary Tract
83%
Genitourinary System
83%
Renal Replacement Therapy
83%
Macrophage
83%
Bladder Cancer
83%
Prostate Cancer
83%
Chronic Kidney Disease
83%
Bladder
83%
Computed Tomography Urography
83%
Cohort Analysis
83%
Extracorporeal Shock Wave Lithotripsy
83%
Inguinal Hernia
83%
Urethra Stenosis
83%
Urethrotomy
83%
Urolithiasis
83%
Hemodialysis
83%
Peritoneal Dialysis
83%
Hernia
83%
Microhematuria
83%
Neoplasm
83%
Prostate Hypertrophy
83%
Transurethral Resection
83%
Sperm Retrieval
83%
Hemostat
83%
Urinary Retention
83%
Mosaicism
83%
Testicular Sperm Extraction
83%
Percutaneous Nephrolithotomy
83%
Lung Metastasis
83%
Pembrolizumab
83%
Computer Assisted Tomography
62%
Hazard Ratio
61%
Benign Prostatic Hyperplasia
52%
Clinical Stage
50%
Ectomesenchyme
41%
Orchiectomy
41%
Adolescent
41%
Neural Crest Cell
41%
Chromosome Deletion Y
41%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
88%
End Stage Renal Disease
83%
Inguinal Hernia
83%
Observational Study
83%
Pembrolizumab
83%
Prostate Specific Antigen
83%
Apoptosis Inhibitor
83%
Prostate Cancer
83%
Hernia
83%
Bladder Cancer
83%
Chronic Periodontitis
83%
Transitional Cell Carcinoma
83%
Hemodialysis
83%
Urolithiasis
83%
Disease Free Survival
16%
Malignant Neoplasm
16%
Cancer Staging
16%
International Classification of Diseases
13%
Abdominal Wall Hernia
13%
Femoral Hernia
13%
Cohort Study
13%
Population Study
13%
Recurrent Disease
10%
Biological Marker
10%
Disease Exacerbation
5%
CD8 Antigen
5%
Disease
5%
Inflammation
5%
Biochemistry, Genetics and Molecular Biology
Inhibitor of Apoptosis
83%
Microdissection
83%
Pembrolizumab
83%
Macrophage
83%
Tumor Necrosis Factor
83%
Anticancer
83%
Prostate-Specific Antigen
83%
Mosaicism
83%
Information Retrieval
83%
Y Chromosome
41%
Estradiol
27%
Prolactin
27%
Luteinizing Hormone
27%
Genotyping
20%
Follicle-Stimulating Hormone
13%
Medical Record
13%
Follitropin Blood Level
13%
Spermatogenesis
13%
Klinefelter Syndrome
13%
Karyotype 47,XXY
13%
Case-Control Study
10%
Medline
10%
Antigen Expression
8%
Ectopic Expression
8%
